Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bio Technology General - BTGC -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (2011)	7/20/2000 12:24:52 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 2028

Bio-Technology General Corp. - Iselin, N.J. 2nd Quar June 30: 2000 1999 Revenue $24,630,000 $22,880,000 Net income 5,463,000 5,100,000 Avg shrs (basic) 54,303,000 52,086,000 Avg shrs (diluted) 57,015,000 53,358,000 Shr earns (basic) Net income .10 .10 Shr earns (diluted) Net income .10 .10 6 Months: Revenue $42,030,000 $43,108,000 Net income 6,948,000 9,106,000 Avg shrs (basic) 54,026,000 52,014,000 Avg shrs (diluted) 57,188,000 53,217,000 Shr earns (basic) Net income .13 .18 Shr earns (diluted) Net income .12 .17